These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21314866)

  • 21. Calcium channel blockers, cancer incidence, and cancer mortality in a cohort of U.S. women: the nurses' health study.
    Michels KB; Rosner BA; Walker AM; Stampfer MJ; Manson JE; Colditz GA; Hennekens CH; Willett WC
    Cancer; 1998 Nov; 83(9):2003-7. PubMed ID: 9806660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive drugs: adverse reactions and metabolic effects in elderly patients.
    Gifford RW
    Geriatrics; 1989 Oct; 44 Suppl B():37-43. PubMed ID: 2572514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
    Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
    Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular pharmacotherapeutic considerations in patients undergoing anesthesia.
    Wolf A; McGoldrick KE
    Cardiol Rev; 2011; 19(1):12-6. PubMed ID: 21135597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular drug therapy in the elderly.
    Aronow WS; Frishman WH; Cheng-Lai A
    Cardiol Rev; 2007; 15(4):195-215. PubMed ID: 17575484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers: should they be stopped or not before ambulatory anaesthesia?
    Smith I; Jackson I
    Curr Opin Anaesthesiol; 2010 Dec; 23(6):687-90. PubMed ID: 20805745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.
    Rejnmark L; Vestergaard P; Mosekilde L
    J Hypertens; 2006 Mar; 24(3):581-9. PubMed ID: 16467662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Temporal trends in pharmacological therapy in the IN-CHF registry from 1995 to 2005].
    Fabbri G; Gorini M; Maggioni AP; Di Lenarda A;
    G Ital Cardiol (Rome); 2007 Feb; 8(2):102-6. PubMed ID: 17402354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sexual dysfunction related to drugs: a critical review. Part IV: cardiovascular drugs.
    La Torre A; Giupponi G; Duffy D; Conca A; Catanzariti D
    Pharmacopsychiatry; 2015 Jan; 48(1):1-6. PubMed ID: 25405774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antihypertensive drugs and fibrinolytic function.
    Fogari R; Zoppi A
    Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns.
    Rywik TM; Rywik SL; Korewicki J; Broda G; Sarnecka A; Drewla J
    Int J Cardiol; 2004 Jun; 95(2-3):177-84. PubMed ID: 15193817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive treatment and erectile dysfunction in a cohort of type II diabetes patients.
    Blumentals WA; Brown RR; Gomez-Caminero A
    Int J Impot Res; 2003 Oct; 15(5):314-7. PubMed ID: 14562130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of erectile dysfunction and peculiarities of its treatment in men with high cardiovascular risk].
    Mamedov MN; Digigova RT; Sharvadze GG; Ugurchieva ZO; Kovrigina MN; Stroeva MV
    Kardiologiia; 2010; 50(11):85-90. PubMed ID: 21526570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex and gender differences in cardiovascular drug therapy.
    Seeland U; Regitz-Zagrosek V
    Handb Exp Pharmacol; 2012; (214):211-36. PubMed ID: 23027453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erectile dysfunction in heart failure patients: a critical reappraisal.
    Alberti L; Torlasco C; Lauretta L; Loffi M; Maranta F; Salonia A; Margonato A; Montorsi F; Fragasso G
    Andrology; 2013 Mar; 1(2):177-91. PubMed ID: 23339018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular drugs and the risk of suicide: a nested case-control study.
    Callréus T; Agerskov Andersen U; Hallas J; Andersen M
    Eur J Clin Pharmacol; 2007 Jun; 63(6):591-6. PubMed ID: 17468865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of cardiovascular drugs on vasodilating endothelial function in animals with experimental deficiency of sex hormones].
    Voronkov AV; Tiurenkov IN
    Eksp Klin Farmakol; 2011; 74(10):23-5. PubMed ID: 22238982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer in cardiovascular drug trials and vice versa: a personal perspective.
    Pfeffer MA
    Eur Heart J; 2013 Apr; 34(15):1089-94. PubMed ID: 22408033
    [No Abstract]   [Full Text] [Related]  

  • 39. Sexual Dysfunction, Cardiovascular Risk and Effects of Pharmacotherapy.
    Imprialos KP; Stavropoulos K; Doumas M; Tziomalos K; Karagiannis A; Athyros VG
    Curr Vasc Pharmacol; 2018 Jan; 16(2):130-142. PubMed ID: 28595561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug therapy and prevalence of erectile dysfunction in the Massachusetts Male Aging Study cohort.
    Derby CA; Barbour MM; Hume AL; McKinlay JB
    Pharmacotherapy; 2001 Jun; 21(6):676-83. PubMed ID: 11401181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.